Synthekine STK-012
Clinical Trial Grant
Administered By
Duke Cancer Institute
Awarded By
Synthekine
Start Date
February 3, 2023
End Date
July 20, 2027
Administered By
Duke Cancer Institute
Awarded By
Synthekine
Start Date
February 3, 2023
End Date
July 20, 2027